In this study, we comprehensively evaluated the role of lncRNA DDX11-AS1 in glioma development and suggested a novel DDX11-AS1/miR-1183/E2F7 axis in the pathogenesis of glioma, providing us with a potential therapeutic target in glioma. This evidence concerns the gene E2F7 and glioma.